Aimovig (erenumab)

pCPA File Number: 21286

Negotiation Status:

Active Negotiation

Indication(s):

migraine, chronic

Sponsor/Manufacturer:

NOVARTIS PHARMACEUTICALS CANADA INC

CADTH Project Number:

SR0578-000

pCPA Engagement Letter Issued:

2021-01-25

Negotiation Process Concluded:

Not Applicable